case_images: PMC4357672_01
case_images: a Color fundus photograph OD demonstrating a nasal peripapillary neovascular membrane with an extension of blood and fluid into the fovea (short arrow). b The corresponding autofluorescent photograph depicts ONHD (long arrow).
case_images: cop-0006-0051-g01.jpg
case_images: PMC4357672_01_cop-0006-0051-g01.jpg
case_images: F1
case_images: The fundus examination revealed peripapillary CNV (fig. 1) with fluid tracking toward the macula. B-scan ultrasonography and autofluorescent photography confirmed the presence of ONHD (fig. 1).
case_images: Macular OCT demonstrating subfoveal fluid and pigment epithelial detachment at initial presentation (a) and subsequent response to ranibizumab (b-d) and aflibercept injections (e-h). Ranibizumab injections were administered at weeks 0, 5, and 10. Aflibercept injections were administered at weeks 15, 25, and 31. OCT images are labeled with corresponding dates.
case_images: cop-0006-0051-g02.jpg
case_images: PMC4357672_01_cop-0006-0051-g02.jpg
case_images: F2
case_images: Ocular coherence tomography (OCT) demonstrated subfoveal fluid (fig. 2). Subsequent treatment with a single aflibercept injection resulted in complete resolution of subfoveal fluid (fig. 2) and an improvement of the patient's BCVA to 20/30 OD. Two additional maintenance aflibercept injections were given during the next 3 months (fig. 2).